Which has the lower trailing P/E, AZN or CVS?

AZN has the lower trailing P/E: AZN trades at 12.77 and CVS at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or CVS?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus CVS at 8.52%.

Does AZN or CVS pay a bigger dividend?

AZN yields 1.89% and CVS yields 2.48% based on trailing dividends and the latest price.

Is AZN or CVS more profitable?

AZN runs the higher net margin — AZN at 17.19% versus CVS at 0.72%.

How have AZN and CVS total returns compared?

Over the past 10 years, AZN delivered 13.96% and CVS delivered 4.62% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs CVS Health Corp. (CVS)

A side-by-side comparison of AstraZeneca PLC and CVS Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$133.67B

$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT

CVS

CVS Health Corp.

$139.51B

$109.34HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — AZN vs CVS

growth of $100 · dividends reinvested · last 30y

AZN +2029.9%CVS +1692.7%AZN compounded faster

AZN CVS

AZN vs CVS: by the numbers

•CVS is the larger company ($139.51B vs $133.67B market cap).
•AZN trades at the lower trailing earnings multiple (12.77 vs 47.17 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.19% vs 0.72% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 8.52% CAGR).
•CVS pays the higher dividend yield (2.48% vs 1.89%).

Metrics side by side

Valuation

Metric	AZN	CVS
P/E ratio	12.77	47.17
Forward P/E	16.58	14.37
P/S ratio	2.19	0.34
P/B ratio	2.80	1.77
PEG ratio	0.29	N/A
EV / EBITDA	7.89	19.53
FCF yield	6.09%	5.40%

Profitability

Metric	AZN	CVS
Gross margin	81.68%	13.87%
Operating margin	23.69%	1.46%
Net margin	17.19%	0.72%
ROE	21.95%	3.79%
ROIC	13.03%	4.72%

Dividends

Metric	AZN	CVS
Dividend yield	1.89%	2.48%
Payout ratio	24.24%	190.00%

Growth (annualized)

Metric	AZN	CVS
Revenue CAGR (5Y)	16.99%	8.52%
EPS CAGR (5Y)	22.02%	-23.89%
FCF CAGR (5Y)	15.68%	-10.57%
Total return CAGR (5Y)	10.56%	8.59%

Frequently asked

Which has the lower trailing P/E, AZN or CVS?: AZN has the lower trailing P/E: AZN trades at 12.77 and CVS at 47.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or CVS?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus CVS at 8.52%.
Does AZN or CVS pay a bigger dividend?: AZN yields 1.89% and CVS yields 2.48% based on trailing dividends and the latest price.
Is AZN or CVS more profitable?: AZN runs the higher net margin — AZN at 17.19% versus CVS at 0.72%.
How have AZN and CVS total returns compared?: Over the past 10 years, AZN delivered 13.96% and CVS delivered 4.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full CVS analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio CVS Health P/E ratio AstraZeneca dividend yield CVS Health dividend yield AstraZeneca ROE CVS Health ROE AstraZeneca operating margin CVS Health operating margin AstraZeneca revenue growth CVS Health revenue growth AstraZeneca free cash flow CVS Health free cash flow

AstraZeneca & CVS Health appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.